New Frontier Data launches its coverage of Federal and Congressional discussions, begins tracking key indicators and disruptors affecting medical cannabis patients and releases the first insights resulting from failure to renew the Rohrabacher-Blumenauer amendment (also called the Rohrabacher-Farr amendment), which prohibited the Justice Department from spending funds to interfere with the implementation of state medical cannabis laws.